Autistic Disorder
146
6
8
109
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
38 trials with published results (26%)
Research Maturity
109 completed trials (75% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
4 terminated out of 146 trials
96.5%
+10.0% vs benchmark
16%
23 trials in Phase 3/4
35%
38 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (146)
Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years
Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
Associative Memory in Autism Spectrum Disorder
Project AFECT (Autism Family Empowerment Coaching and Training Program)
Relationship Training for Children With Autism and Their Peers
Validation Digital Bio-markers During Sulforaphane Treatment.
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
Autism Traits in Adolescents With Social Anxiety Disorder: Associations With Parental Broader Autism Phenotype
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism
Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
Impact of Improving Gastrointestinal Symptoms on Autism Symptoms and Oxidative Stress
Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD)
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder